- Home
- REPL vs SBH Comparison
REPL vs SBH Comparison
Compare REPL & SBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REPL | SBH |
|---|---|---|
| Founded | 2015 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | REPL | SBH |
|---|---|---|
| Price | $10.82 | $16.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $19.50 | $17.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.17 |
| EPS | N/A | ★ 1.43 |
| Revenue | N/A | ★ $3,701,424,000.00 |
| Revenue This Year | N/A | $0.82 |
| Revenue Next Year | $497.81 | $1.51 |
| P/E Ratio | ★ N/A | $11.97 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.50 | $11.54 |
| 52 Week High | $16.33 | $17.92 |
Technical Indicators
Market Signals| Indicator | REPL | SBH |
|---|---|---|
| Relative Strength Index (RSI) | 32.47 | 54.52 |
| Support Level | $6.81 | $15.09 |
| Resistance Level | $11.05 | $17.01 |
| Average True Range (ATR) | 0.71 | 0.54 |
| MACD | -0.20 | 0.04 |
| Stochastic Oscillator | 1.83 | 56.81 |
Price Performance
Historical ComparisonAbout REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.